Clinical trial

Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer…

NCT00002711 · Memorial Sloan Kettering Cancer Center, Other · Completed

Key facts

NCT number NCT00002711
Title Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Official title A PHASE I TRIAL OF COMBINED MODALITY THERAPY FOR LOCALIZED ESOPHAGEAL CANCER: CISPLATIN-PACLITAXEL FOLLOWED BY RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ESCALATING DOSES OF PACLITAXEL
Lead sponsor Memorial Sloan Kettering Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Esophageal Cancer
Intervention type Drug, Radiation
Interventions chemotherapy, cisplatin, paclitaxel, low-LET electron therapy, low-LET photon therapy
Enrollment 24
Start date Oct 1, 1995
Primary completion Oct 1, 2000
Completion Oct 1, 2000
First posted Aug 24, 2004
Last update posted Jul 3, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies